/Investor DB

BVCF

Venture capital

Shanghai · Series A–Late Stage · 18 people tracked

Find your way into BVCF

1,115 people in our graph share verified history with the BVCF team — schools, employers, funds. One of them is your warm intro.

Haim Broshunlockedknows Ofir Hazut · together at Trendlines Group (overlapped)
knows the team · via 8400 The Health Network
×8knows the team · via Fudan University
×2knows the team · via Bar-Ilan University
✨ Fox Verdict
Sign up to see your fit

Investment thesis

BVCF concentrates on the Chinese life sciences sector, aiming to create and grow innovative companies with global reach. Since its founding in 2005, the firm has sought to advance health outcomes while generating returns, positioning itself at the intersection of Chinese and global life sciences markets. It has drawn global institutional financial and strategic investors to support this mission.

Source: firm website, verified Sep 29, 2026.

Stage
Series A–Late Stage
Check
$5M
HQ
Shanghai, CN
Instruments
Equity
Founded
2005
AUM
$400M
VC funds
3
Tracked investments
7
IPOs
2

Team · 18 people

from the firm's website & curated & public directories
Vanessa Huang· General Partner
Huacheng Wei· General Partner
Jadium Chen· Managing Director
Yunlong Huang· Managing Director
Yong Wang· Investor
Bing Zhuo· Investorin

What they invest in

from 5 of 7 portfolio companies

Biotech ×4Healthtech ×3Digital Health ×2Medical Devices ×2AI & Machine Learning ×1E-commerce ×1Logistics & Supply Chain ×1SaaS ×1

HQs:United States×3Switzerland×1

Investments · 7 tracked

founders shown can be your intro path

By year:2025 · 12021 · 22015 · 12014 · 26 dated

Jaguar Healthjaguar.healthNASDAQ: JAGXSeries A · Feb 2014 · $7M

Jaguar Health is a pharmaceutical company developing crofelemer, including a novel powder for oral solution formulation, for gastrointestinal conditions and rare intestinal failure indications such as microvillus inclusion disease (MVID) and short bowel syndrome with intestinal failure (SBS-IF) in adults and children.

BiotechDigital HealthHealthtechSan Francisco, US

Lisa Conte(Executive Officer, Director)Carol Lizak(Executive Officer)Pravin Chaturvedi(Executive Officer)Steven King(Executive Officer)inJonathan Wolin(Executive Officer)inSerge Martinod(Executive Officer)

Co-investorsDigitalDx Ventures

SPS Commercespscommerce.comin𝕏NASDAQ: SPSC

SPS Commerce is a supply chain and retail network software company that enables retailers, suppliers, and logistics partners to manage inventory, orders, and supply chain operations.

AI & Machine LearningE-commerceLogistics & Supply ChainSaaSMinneapolis, US

Chad Collins(Chief Executive Officer)inJim Frome(Executive Officer)inKim Nelson(Executive Officer)inDan Juckniess(Executive Officer)inJamie Thingelstad(Executive Vice President & Chief Technology Officer)inArchie C. Black(Executive Officer, Director)in

Co-investorsPartinc CapitalSeyen CapitalCID CapitalSplit Rock Partners

Cellenkoscellenkosinc.comSeries A · Nov 2021 · $15M

Cellenkos is a clinical-stage biotechnology company developing allogeneic, tissue-targeted, cord blood-derived regulatory T cell (T-REG) therapies.

BiotechHealthtech

DiaCartadiacarta.comSeries A · Jan 2015 · $8M

DiaCarta is a precision diagnostics company developing molecular technologies (XNA and isobDNA) to detect genetic mutations for cancer patient management—covering early detection, diagnosis, therapy selection, and monitoring—as well as infectious disease testing.

BiotechDigital HealthMedical Devices

Oculisoculis.cominSeries C · May 2021 · $57M

Oculis is a biopharmaceutical company developing pharmaceutical drug products, with a focus on ophthalmic and eye disease treatments.

BiotechHealthtechMedical DevicesBoston, CH

Riad Sherif(Chief Executive Officer)in

Co-investorsBay City CapitalBrunnur Ventures GPPivotal Life SciencesVI Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

CARsgen TherapeuticsQiselian Biotechnology

Exits · 2

2 IPOs

Jaguar HealthNASDAQ: JAGXSPS CommerceNASDAQ: SPSC

Portfolio news

latest coverage across their companies

IPO stake values · per SEC filings

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
SPS Commerce11.4%$12.25Dec 2010$16.4M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has BVCF made?
BVCF has 7 tracked investments, 2 of which have exited, including 1 dated in the last 24 months.
What stage does BVCF invest at?
BVCF invests at the Series A, Series B, Late Stage stages.
What is BVCF's typical check size?
BVCF typically writes checks of $5M.
What sectors does BVCF focus on?
BVCF focuses on Biotech, Healthtech, Medical Devices.
Where is BVCF located?
BVCF is headquartered in Shanghai, CN.

Media · Podcasts & interviews

featuring the team

Five Questions For BVCF's Founder Dr. Zhi Yang

China Money Network · Zhi Yang

Co-investors · 2

Pivotal Life Sciences

Pivotal Life Sciences is a global healthcare investment firm backing companies developing high-impact therapeutics for major unmet medical needs, operating across venture capital, venture building, and public equity strategies.

Both backed · 1
Earlybird Venture Capital

Earlybird Venture Capital is a European venture capital investor that backs early-stage technology founders with capital, strategic support, and access to an international network.

$540K – $12M

Firms observed investing alongside BVCF, from public investor directories. Shared companies are the overlap with BVCF's recorded portfolio.

Similar investors

Featured in lists